![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png)
Meanwhile, the second American Ebola patient arrived Tuesday in Atlanta from Liberia. Nancy Writebol, 59, was taken to Emory University Hospital, where she joined Dr. Kent Brantly, who arrived from Saturday.
Both aid workers were infected despite taking precautions as they treated Ebola patients at a clinic in Liberia.
Family members said both Americans have been improving after taking the experimental drug; the hospital has not released any information on their conditions. Writebol's employer, the SIM charity, said Tuesday that she remains in serious but stable condition.
The experimental treatment the two were given was developed with U.S. military funding by a San Diego company, using antibodies from lab animals that had been injected with parts of the Ebola virus. Tobacco plants in Kentucky are being used to make the drug, which hasn't yet been tested in humans.
It's impossible to know whether the drug saved these workers, stressed Dr. Tom Frieden, direct of the CDC in Atlanta.
"Every medicine has risks and benefits," he said to reporters at a health symposium in Kentucky. "Until we do a study, we don't know if it helps, if it hurts, or if it doesn't make any difference."
If this treatment works, it could create pressure to speed through testing and production to help contain the disease in Africa. Dozens of African heads of state were meeting with President Barack Obama on Tuesday at a summit in Washington. But it could take years before any treatment can be proven to be effective and safe.
Both aid workers were infected despite taking precautions as they treated Ebola patients at a clinic in Liberia.
Family members said both Americans have been improving after taking the experimental drug; the hospital has not released any information on their conditions. Writebol's employer, the SIM charity, said Tuesday that she remains in serious but stable condition.
The experimental treatment the two were given was developed with U.S. military funding by a San Diego company, using antibodies from lab animals that had been injected with parts of the Ebola virus. Tobacco plants in Kentucky are being used to make the drug, which hasn't yet been tested in humans.
It's impossible to know whether the drug saved these workers, stressed Dr. Tom Frieden, direct of the CDC in Atlanta.
"Every medicine has risks and benefits," he said to reporters at a health symposium in Kentucky. "Until we do a study, we don't know if it helps, if it hurts, or if it doesn't make any difference."
If this treatment works, it could create pressure to speed through testing and production to help contain the disease in Africa. Dozens of African heads of state were meeting with President Barack Obama on Tuesday at a summit in Washington. But it could take years before any treatment can be proven to be effective and safe.